We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $160M
1-Year Est. Return 8.57%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+8.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$10.6M
Cap. Flow
+$11.7M
Cap. Flow %
7.76%
Top 10 Hldgs %
48.89%
Holding
53
New
7
Increased
21
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$10.5M
2
HRTX icon
Heron Therapeutics
HRTX
+$2.69M
3
TGTX icon
TG Therapeutics
TGTX
+$2.69M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$2.57M
5
ABMD
Abiomed Inc
ABMD
+$2.56M

Top Sells

Rank Stock Value
1
AVXS
AveXis, Inc. Common Stock
AVXS
+$2.78M
2
PBYI icon
Puma Biotechnology
PBYI
+$2.66M
3
ABLX
Ablynx NV
ABLX
+$2.63M
4
TVTX icon
Travere Therapeutics
TVTX
+$2.57M
5
XLRN
Acceleron Pharma
XLRN
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 47.81%
2 Financials 29.15%
3 Consumer Discretionary 10.46%
4 Industrials 2.95%
5 Communication Services 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
51
DELISTED
Express Scripts Holding Company
ESRX
– –
-28,172
Closed -$1.95M
ABLX
52
DELISTED
Ablynx NV
ABLX
– –
-48,194
Closed -$2.63M
AVXS
53
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-22,474
Closed -$2.78M
1 2
3

Similar funds

SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
LCA
Legend Capital Advisors New York $160M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM

Emory University's Q2 2018 Portfolio in Review

As of Q2 2018, Emory University held 53 positions worth $151M, up 7.6% from $140M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Emory University deployed $11.7M of net new capital in Q2 2018, opening 7 new positions and adding to 21 existing holdings. Its largest new stake was Heron Therapeutics: 84,475 shares worth $3.28M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 53% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Myovant Sciences Ltd., an estimated $1.16M trimmed.

  • Emory University's largest Q2 2018 buy was Heron Therapeutics: 84,475 shares worth $3.28M.
  • Emory University added most to JD.com in Q2 2018, an estimated $10.5M increase.
  • Emory University's biggest Q2 2018 reduction was Myovant Sciences Ltd., cutting an estimated $1.16M.
  • Emory University fully exited AveXis, Inc. Common Stock in Q2 2018, selling an estimated $2.78M.
  • Emory University's ten largest holdings make up 49% of its $151M portfolio in Q2 2018.
  • Emory University opened 7 new positions and closed 7 in Q2 2018.
  • Emory University's portfolio value rose 7.6% quarter-over-quarter to $151M.

Based on Emory University's 13F filing for Q2 2018, filed 14 Aug 2018.